Thrilled to share with you our latest publication on the use of Cerebrolysin to potentiate the antidepressant effect of lithium in rats. This achievement holds a special significance for me as it is my first publication as a first author. The article entitled "Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression" was published in the Journal of Psychiatric Research (IF: 4.8, Q1). Our findings suggest the use of Cerebrolysin as an adjuvant therapy with lithium and the need for further investigation on the use of Cerebrolysin as an adjuvant with lithium and other antidepressants. Cerebrolysin is a commercially available drug used for the treatment of different cerebrovascular disorders like stroke, traumatic brain injury and cognitive impairment. If you are interested in learning more, you can read the full-text article through this link https://lnkd.in/dwpaRFp4 or access through your institution https://lnkd.in/dGPyWiMz =============================== You can also read our previous related article entitled "Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine" here https://lnkd.in/d2sTxPGc #neuroscience #neurophysiology #neuropsychology #depression #parkinsons #lithium #brain #research
Congratulations on your first-author publication--a milestone indeed! Have you considered exploring the molecular mechanisms that underpin the synergistic effects of Cerebrolysin with lithium?
Congrats Ahmed ❤️❤️ You really deserved it 💪
congratulations
Congratulation
Congratulations my friend ❤️ Keep going 💪
مبااارك💖
Congratulations ❤️
congrats👏🏻❤️
Congratulations Ahmed, keep going 👏
BSc in Chemistry & Zoology
8moI am grateful to my co-authors and the research team for their collaboration and support throughout this journey. Engy Khaled Alaa Abdelrahman AyaTallah Elgohary Yasmina M. Ebrahim Abdelaziz Alazoul Hossam Ismail Alaa Sakraan, PGDE, MSc